Related Party Transactions (Details Narrative) - USD ($)	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022	Nov. 24, 2020
Related Party Transaction [Line Items]
Aggregate fair value of stock payable		$ 50,750
Number of shares in stock payable		750,000
Common stock issued to officers	84,200	$ 203,000
Unamortized debt discount premium	$ 0	$ 0
Kanativa Inc [Member]
Related Party Transaction [Line Items]
Number of common stock shares issued	24,000,000
Ownership percentage	100.00%
Common Stock [Member]
Related Party Transaction [Line Items]
Common stock issued to officers, shares	4,250,000	3,000,000
Common stock issued to officers	$ 425	$ 300
Related Party [Member]
Related Party Transaction [Line Items]
Due to officer	58,400	45,000
Convertible notes payable	65,000	56,037
Unamortized debt discount premium	0	8,963
Related Party [Member] \| Financing Arrangement [Member]
Related Party Transaction [Line Items]
Convertible notes payable	65,000	56,037
Unamortized debt discount premium	8,963	$ 8,963
Chief Executive Officer [Member]
Related Party Transaction [Line Items]
Working capital	58,400
Working capital advances	$ 13,400
Imputed interest on advance rate	10.00%	10.00%
Imputed interest amount	$ 4,871	$ 4,500
Number of stock authorized for issuance	2,500,000
Common stock issued to officers, shares	500,000	1,000,000
Chief Executive Officer [Member] \| Every Quarter From July 1, 2021 To October 1, 2023 [Member]
Related Party Transaction [Line Items]
Number of stock authorized for issuance	250,000
Chief Financial Officer [Member]
Related Party Transaction [Line Items]
Number of stock authorized for issuance	2,500,000
Common stock issued to officers, shares	500,000	1,000,000
Chief Financial Officer [Member] \| Every Quarter From July 1, 2021 To October 1, 2023 [Member]
Related Party Transaction [Line Items]
Number of stock authorized for issuance	250,000
Chief Operating Officer [Member]
Related Party Transaction [Line Items]
Number of stock authorized for issuance	1,000,000		1,000,000
Common stock issued to officers, shares	250,000	1,000,000
Chief Operating Officer [Member] \| Every Quarter From July 1, 2022 To July 1, 2023 [Member]
Related Party Transaction [Line Items]
Number of stock authorized for issuance	250,000
Chief Executive Officer and Shareholder [Member] \| Financing Arrangement [Member]
Related Party Transaction [Line Items]
Fair value of notes payable				$ 65,000

NEXIEN BIOPHARMA, INC. 10-K